FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
85 letters match. Newest first.
-
DrugsChongqing Qiancan Technology Co., Ltd.
Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.
High risk -
DrugsTianjin Healthcare Medical Technology Co., Ltd.
Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.
High risk -
DrugsLovelace Biomedical Research Institute
Lovelace Biomedical's quality unit failed to ensure final drug study reports matched raw data, FDA says.
Medium -
DrugsVeganicSKN Limited
FDA warns VeganicSKN over manufacturing rule failures; drug shipped after failing test and high-risk ingredient not identity-tested.
High risk -
DrugsAeroflex Industria de Aerosol Ltda.
Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.
High risk -
DrugsHealthPartners Neuroscience Center Research and Innovation
FDA warned HealthPartners Neuroscience Center that its animal studies of an investigational drug violated good laboratory practice rules.
Medium -
DrugsIntas Pharmaceuticals Limited
FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.
High risk -
DrugsVedic Lifesciences Pvt. Ltd.
FDA warns Vedic Lifesciences over false final reports for three nonclinical drug studies.
Medium -
DevicesPalamur Biosciences Private Limited
FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.
High risk -
DrugsPersōn & Covey, Inc.
FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.
High risk -
DrugsMedia Networks Sydney Pty. Limited
FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.
High risk -
DevicesJiangsu Kerbio Medical Technology Group Co.
FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.
High risk -
DevicesCCIC Huatongwei International Inspection Co., Ltd.
FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.
High risk -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
DrugsViatris, Inc.
FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.
High risk -
DevicesMid-Link Testing Company, Ltd
FDA warns Mid-Link Testing over unreliable Good Laboratory Practice (GLP) safety data for medical device tests.
High risk -
DevicesSanitation & Environmental Technology Institute dba SDWH
FDA found GLP violations in SDWH's nonclinical testing of medical devices, raising doubts about safety data.
High risk -
DevicesJiangsu Shenli Medical Production Co., Ltd.
FDA: Chinese syringe maker Jiangsu Shenli lacked design controls and device master records, halting US imports.
High risk -
DrugsJiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA found data integrity failures and inadequate sterile manufacturing controls at Jiangsu Hengrui Pharmaceuticals' drug facility.
High risk -
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
DrugsGulf States International, Inc.
Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.
Medium -
DrugsMaison Blanche LLC
FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.
Medium -
DevicesIntegra LifeSciences Corporation
FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.
High risk -
DrugsCergomex Imports, LLC
Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.
Medium -
DrugsGTP International Corp
GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.
Medium -
DrugsSkyline Herbals Private Limited
FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.
High risk -
DevicesZYTO Technologies, Inc.
FDA warns ZYTO over unapproved disease claims for Hand Cradle GSR and quality-system failures.
High risk -
DrugsChengdu KeCheng Fine Chemicals Co., Ltd.
FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.
High risk -
DrugsDrivergent, Inc.
Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.
High risk -
DrugsNuGeneration Technologies LLC
FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.
High risk -
DrugsKobayashi Healthcare International, Inc.
Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.
High risk -
DrugsMohawk Laboratories Division of NCH Corporation
FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.
High risk -
DrugsUrban Electric Power
Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.
High risk -
DevicesEmpowered Diagnostics LLC
Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.
High risk -
DrugsThe Anthos Group, Inc.
Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.
Medium -
BiologicsValley Biosystems
FDA cited Valley Biosystems, a California biologics testing lab, for Good Laboratory Practice violations that call its nonclinical study data into question.
High risk -
DrugsJose Miguel Gutierrez Salas
FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.
High risk -
DrugsGuangzhou Orchard Aromatherapy & Skin Care Co., Ltd.
Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.
High risk -
DrugsDDI Multinacional S.A. de C.V.
DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.
High risk -
DrugsNoticias Mexico Hoy Grupo Multimedia, S.A. de C.V.
Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.
High risk -
DrugsMirfeel Korea Co., Ltd.
Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.
High risk -
DrugsIndustrias Cklass S. de R.L. de C.V.
FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.
High risk -
DrugsDavid Cosmetic Co., Ltd.
FDA lab testing found benzene, a cancer-causing impurity, at about 6 ppm in David Cosmetic's CALA hand sanitizer, making it adulterated.
High risk -
BiologicsToxikon Corporation/Labcorp Bedford LLC
FDA warned Toxikon/Labcorp Bedford over GLP violations in a biologics nonclinical study, including incorrect kidney-function calculations and failed QA review.
Medium -
DrugsMaquiladora Miniara SA de CV
Maquiladora Miniara's Shine and clean Hand Sanitizer Gel was found to contain methanol instead of labeled ethanol.
High risk -
DrugsGuangdong Kemei Pharmaceutical Technology Co. Ltd.
FDA says Guangdong Kemei's IMC hand sanitizer labeled 75% ethanol contained methanol and was refused at U.S. border.
High risk -
DrugsGuangzhou Shiruoni Cosmetics Co., Ltd
Guangzhou Shiruoni Cosmetics' hand sanitizer labeled as 75% isopropyl alcohol contained ethanol instead and was misbranded as FDA-approved.
High risk -
DrugsBionateo Sp. z.o.o.
Bionateo, a Polish drugmaker, shipped hand sanitizer contaminated with methanol and isopropanol that FDA refused at the U.S. border.
High risk -
DrugsDongBang Cosmetics Co., Ltd.
DongBang Cosmetics of Incheon shipped a hand sanitizer labeled 62% alcohol that tested at 55%, and it was refused at the U.S. border.
High risk